Regentis Biomaterials (Israel)
GelrinC potentially offers a solution that gives surgeons a cost-effective product and a simple-to-perform procedure providing patients with sustained pain relief and functional improvement. GelrinC is already approved as a device with a CE mark in Europe, and we plan to look for strategic partners in Europe in connection therewith. In the US, we are conducting clinical trials towards PMA (see clinical development).
Basic Information
- Category: Business
- Website: http://www.regentis.co.il/
Documented Facts
- Email: egeller@medicavp.com (No linked source recorded for this statement.)
Evidence and Sources
Citation Guidance
Explore Business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Regentis Biomaterials (Israel).
- Canonical profile: https://brandsource.ai/brands/regentis-biomaterials-israel
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/regentis-biomaterials-israel/json-ld
- Citation profile API: https://brandsource.ai/api/brands/regentis-biomaterials-israel/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (77/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-23
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
GelrinC potentially offers a solution that gives surgeons a cost-effective product and a simple-to-perform procedure providing patients with sustained pain relief and functional improvement. GelrinC is already approved as a device with a CE mark in Europe, and we plan to look for strategic partners in Europe in connection therewith. In the US, we are conducting clinical trials towards PMA (see clinical development).
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 1 structured fact available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.